跳到主要內容

Gibson Christopher 的 Form 4 申報

Recursion Pharmaceuticals, Inc.(RXRX),2022/11/4 申報

申報編號
0001209191-22-055870
申報時間
2022/11/4
交易日
2022/11/3
申報延遲
1 天
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 10 筆非衍生性交易、5 筆衍生性交易。公開市場賣出合計 $39.2 萬。交易後 1 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Gibson ChristopherCIK 0001856369董事、高階主管(執行長)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2022/11/3Class A Common StockM行使選擇權取得+31,250$2.48+$77,500594,209直接
2022/11/3Class A Common StockS賣出處分−18,193$9.89F2−$179,928.77576,016直接
2022/11/3Class A Common StockC轉換取得+18,500$0.00$0594,516直接
2022/11/3Class A Common StockS賣出處分−18,500$10.11F4−$187,035576,016直接
2022/11/3Class A Common StockC轉換取得+500$0.00$0500間接
2022/11/3Class A Common StockS賣出處分−500$10.11F6−$5,0550間接
2022/11/3Class A Common StockC轉換取得+1,000$0.00$01,000間接
2022/11/3Class A Common StockS賣出處分−1,000$10.10F8−$10,1000間接
2022/11/3Class A Common StockC轉換取得+1,000$0.00$01,000間接
2022/11/3Class A Common StockS賣出處分−1,000$10.10F10−$10,1000間接

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2022/11/3Class A Common StockC轉換處分−18,500$0.00$06,695,834直接
2022/11/3Class A Common StockM行使選擇權處分−31,250$0.00$0812,500直接
2022/11/3Class A Common StockC轉換處分−500$0.00$0541,000間接
2022/11/3Class A Common StockC轉換處分−1,000$0.00$0532,000間接
2022/11/3Class A Common StockC轉換處分−1,000$0.00$0128,875間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

This transaction was executed in multiple trades at prices ranging from $9.88 to $10.06. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

F4

This transaction was executed in multiple trades at prices ranging from $9.88 to $10.45. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

F6

This transaction was executed in multiple trades at prices ranging from $9.93 to $10.41. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

F8

This transaction was executed in multiple trades at prices ranging from $9.88 to $10.41. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

F10

This transaction was executed in multiple trades at prices ranging from $9.88 to $10.41. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)